2360 related articles for article (PubMed ID: 26511653)
1. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
2. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
3. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
4. Production of Cardiomyocytes from Human Pluripotent Stem Cells by Bioreactor Technologies.
Halloin C; Coffee M; Manstein F; Zweigerdt R
Methods Mol Biol; 2019; 1994():55-70. PubMed ID: 31124104
[TBL] [Abstract][Full Text] [Related]
5. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.
Kempf H; Kropp C; Olmer R; Martin U; Zweigerdt R
Nat Protoc; 2015 Sep; 10(9):1345-61. PubMed ID: 26270394
[TBL] [Abstract][Full Text] [Related]
6. Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules.
Kempf H; Zweigerdt R
Adv Biochem Eng Biotechnol; 2018; 163():39-69. PubMed ID: 29071404
[TBL] [Abstract][Full Text] [Related]
7. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
8. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol.
Fonoudi H; Ansari H; Abbasalizadeh S; Blue GM; Aghdami N; Winlaw DS; Harvey RP; Bosman A; Baharvand H
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500408
[TBL] [Abstract][Full Text] [Related]
9. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
10. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.
Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM
Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693
[TBL] [Abstract][Full Text] [Related]
11. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
Kempf H; Andree B; Zweigerdt R
Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
[TBL] [Abstract][Full Text] [Related]
12. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
[TBL] [Abstract][Full Text] [Related]
13. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
[TBL] [Abstract][Full Text] [Related]
14. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes.
Correia C; Koshkin A; Duarte P; Hu D; Carido M; Sebastião MJ; Gomes-Alves P; Elliott DA; Domian IJ; Teixeira AP; Alves PM; Serra M
Biotechnol Bioeng; 2018 Mar; 115(3):630-644. PubMed ID: 29178315
[TBL] [Abstract][Full Text] [Related]
15. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
[TBL] [Abstract][Full Text] [Related]
16. Generation and purification of human stem cell-derived cardiomyocytes.
Schwach V; Passier R
Differentiation; 2016; 91(4-5):126-38. PubMed ID: 26915912
[TBL] [Abstract][Full Text] [Related]
17. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.
Lian X; Hsiao C; Wilson G; Zhu K; Hazeltine LB; Azarin SM; Raval KK; Zhang J; Kamp TJ; Palecek SP
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):E1848-57. PubMed ID: 22645348
[TBL] [Abstract][Full Text] [Related]
18. Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations.
Hamad S; Derichsweiler D; Papadopoulos S; Nguemo F; Šarić T; Sachinidis A; Brockmeier K; Hescheler J; Boukens BJ; Pfannkuche K
Theranostics; 2019; 9(24):7222-7238. PubMed ID: 31695764
[TBL] [Abstract][Full Text] [Related]
19. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates.
Farzaneh Z; Najarasl M; Abbasalizadeh S; Vosough M; Baharvand H
Stem Cells Dev; 2018 Feb; 27(4):262-274. PubMed ID: 29298619
[TBL] [Abstract][Full Text] [Related]
20. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
